Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Linde AG    LIN   DE0006483001

LINDE AG (LIN)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Linde : Ceylon Oxygen reveals world class easy-to-use medical gas solutions at SAARC conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/20/2017 | 02:50pm CET

Ceylon Oxygen Ltd. (COL), a member of The Linde Group, showcased its world class patient care products and solutions at the 12th SAARC Association of Anaesthesiology conference held in Colombo recently. The event was inaugurated by President Maithripala Sirisena.

The premier South Asian Association for Regional Cooperation (SAARC) organisation for anaesthesiologists was hosted and conducted by the College of Anaesthesiologists and Intensivists of Sri Lanka, in combination with the 33rd Annual Academic Congress of the College. The theme of this year's event was 'Improving outcome after anaesthesia and critical care in the SAARC region'.

COL Managing Director Radesh Daluwatte said, 'We are privileged to have been invited to participate at this conference that brings together leading experts and healthcare leaders from across the world and the South Asia region. COL has been and continues to work closely together with the Sri Lankan government and the College of Anaesthesiologists and Intensivists of Sri Lanka to help raise the standards and quality of patient care in Sri Lanka.'

He added, 'COL is committed to providing innovative, easy-to-use medicinal gas solutions and services. Our CONOXIA high quality medical oxygen product is packaged in a lightweight aluminium cylinder with a Linde Integrated Valve (LIV) that eases oxygen administration to patients. Linde ENTONOX is a medicinal nitrous oxide/oxygen mixture solution that is administered by inhalation and there is no need to insert a cannula or set up an intravenous line. Our QI Medical Gas Services portfolio is designed to support hospitals and other care facilities in meeting best practice standards for quality, safety and security in all aspects of medical gas delivery.'

© Pakistan Press International, source Asianet-Pakistan

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LINDE AG
03/20 LINDE : Ceylon Oxygen reveals world class easy-to-use medical gas solutions at S..
03/18 LINDE PAKISTAN : Change of Date and Time of Linde Pakistan Limited
03/16 LINDE : strengthens its role in the Shell Ecomarathon
03/16 LINDE : strengthens its role in the Shell Eco-marathon
03/15 DGAP-DD : Linde AG deutsch
03/15 DGAP-DD : Linde AG english
03/15 LINDE : 15.03.2017 / Corporate News / Linde strengthens its role in the Shell Ec..
03/15 LINDE AG : Linde strengthens its role in the Shell Eco-marathon
03/15 LINDE AG : Linde verstärkt sein Engagement beim Shell Eco-Marathon
03/14 LINDE : invests over EUR 110 million in China to strengthen position as supplier..
More news
Sector news : Industrial Gas
01:15p AKZO NOBEL CEO : won't meet with PPG to talk about bid
11:47a AKZO NOBEL : PPG's McGarry in Amsterdam to promote 'compelling' Akzo offer
07:48aDJPaint Giant Pushed on Deal -- WSJ
03/22DJElliott Steps Up Pressure as Akzo Spurns New PPG Bid -- 5th Update
03/22 AKZO NOBEL : CEO - won't meet with PPG to talk about bid
More sector news : Industrial Gas
News from SeekingAlpha
03/09 Linde AG's (LNAGF) CEO Aldo Belloni on Q4 2016 Results - Earnings Call Transc..
03/09 Linde AG 2016 Q4 - Results - Earnings Call Slides
03/09 Linde AG ADR reports FY results
03/09 Linde AG reports FY results
02/22 What This 27-Year-Old's Portfolio Looks Like
Advertisement
Financials (€)
Sales 2017 17 803 M
EBIT 2017 2 306 M
Net income 2017 1 274 M
Debt 2017 6 600 M
Yield 2017 2,59%
P/E ratio 2017 22,48
P/E ratio 2018 18,79
EV / Sales 2017 1,94x
EV / Sales 2018 1,83x
Capitalization 27 916 M
More Financials
Chart LINDE AG
Duration : Period :
Linde AG Technical Analysis Chart | LIN | DE0006483001 | 4-Traders
Full-screen chart
Technical analysis trends LINDE AG
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 29
Average target price 164 €
Spread / Average Target 8,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Aldo Belloni Chief Executive Officer
Wolfgang W. Reitzle Chairman-Supervisory Board
Sven Schneider Chief Financial Officer & Member-Executive Board
Andreas Opfermann Head-Technology & Innovation
Sandeep Sen Head-Group Information Services
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LINDE AG-3.72%30 147
AIR LIQUIDE0.33%44 521
SHIN-ETSU CHEMICAL CO ..4.40%36 767
LYONDELLBASELL INDUSTR..2.76%35 483
PRAXAIR, INC.-0.10%33 397
AIR PRODUCTS & CHEMICA..-5.15%29 681
More Results